NCT07339059 2026-01-30SG and Immunotherapy as Maintenance Therapy for Extensive-stage Small-cell Lung CancerHenry Ford Health SystemPhase 2 Recruiting35 enrolled
NCT06055465 2025-05-15Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung CancerChinese University of Hong KongPhase 2 Recruiting37 enrolled